MANISH NAIR: Open Payments
NPI 1851531982 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 18 payments from 10 companies in 2025. Trend: 2023 $71 · 2024 $33 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Vertical Pharmaceuticals, LLC | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Corium, LLC | 1 | $9 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Relexxii, Jornay PM, ARISTADA, ZURZUVAE, LOREEV XR.
Industry payments across TX — which companies pay providers there.
